Keyphrases
Copolymer
81%
E-selectin
64%
Cell-penetrating Peptide
59%
Peptide-polymer Conjugates
59%
N-(2-hydroxypropyl)methacrylamide Copolymers
51%
Therapeutic Use
43%
Cancer Cells
43%
Diagnostic Applications
42%
HPMA Copolymers
39%
Polymer-drug Conjugates
37%
Doxorubicin
35%
Nanomedicine
33%
Doxorubicin Conjugates
32%
Polyion Complex
30%
Polymer Conjugates
30%
Overexpressing
30%
Dendritic Cells
29%
Drug Delivery
28%
Biorecognition
27%
Nanoparticles
26%
Therapeutic Agents
26%
Endothelial Cells
25%
Intracellular Delivery
25%
Anticancer Drugs
24%
Polyethylenimine
24%
Peptide Conjugates
23%
Polyethylene Glycol
23%
IR783
22%
Pro-apoptotic Peptide
22%
Pharmaceutical Carriers
21%
Site-specific Delivery
21%
Cargo
21%
Metastatic Tumor
21%
Colorectal Cancer
21%
CD44v
20%
Microparticles
19%
Liposomes
19%
Versatile Applications
19%
Therapeutic Efficacy
19%
Paclitaxel
19%
Small Interfering RNA (siRNA)
19%
Polymer Bound
19%
Drug-free
19%
Galactose
18%
Binding Peptide
17%
Tumor
17%
Tumor Microenvironment
17%
Nanoparticulate
16%
Cluster of Differentiation 44 (CD44)
15%
Targeted Delivery
15%
Pharmacology, Toxicology and Pharmaceutical Science
Copolymer
100%
Malignant Neoplasm
78%
Neoplasm
59%
Cell Penetrating Peptide
59%
E-Selectin
59%
Doxorubicin
59%
Mouse
59%
N (2 Hydroxypropyl)methacrylamide Copolymer
50%
Drug Conjugate
40%
Nanomedicine
33%
Nanoparticle
29%
Fluorescein Isothiocyanate
29%
Cytotoxicity
28%
Metastasis
23%
Anticarcinogen
23%
Colorectal Cancer
21%
Microparticle
19%
Micelle
19%
Liposome
19%
Paclitaxel
19%
Small Interfering RNA
19%
Combination Therapy
19%
Drug Delivery System
19%
Galactose
17%
Tumor Microenvironment
17%
Drug Carrier
16%
Cell Adhesion Molecule
15%
Lactose
15%
Galactoside
14%
Polyacrylic Acid
14%
Enteric Coating
14%
Tumor Growth
14%
Colon Adenocarcinoma
14%
Polyethyleneimine
14%
Primary Tumor
13%
Macrogol
12%
Hyaluronic Acid
12%
Complexation
11%
Colon Cancer
11%
Galectin 3
10%
Bioactive Drug
9%
Peptide Drug Delivery
9%
Polyanion
9%
Controlled Release
9%
Vasculotropin Receptor 1
9%
Selectin (Glycoprotein)
9%
Colorectal Liver Metastasis
9%
Alanine Aminopeptidase
9%
Liver Injury
9%
Liver Cell Carcinoma
9%